North America Diagnostic Imaging Market – Industry Analysis and Market Forecast (2019-2027) _ by Products, Applications, End-User, and Geography


North America Diagnostic Imaging Market is expected to reach USD XX Billion by 2027 from USD XX Billion in 2019 at a CAGR of XX% (Detailed analysis of the market CAGR is provided in the report).

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.



To know about the Research Methodology:-Request Free Sample Report

Diagnostic imaging allow doctors to look inside body for clues related to any sort of medical condition. A selection of machines and techniques help create pictures of the structures and activities occurring inside body. The type of imaging preferred by doctor depends on symptoms and the body part being examined. There are many imaging tests that are painless and easy, yet some requires one to stay still for a longer period of time inside a machine, which can be uncomfortable. Some of these tests involve exposure to a small amount of radiation as well and in some cases may even add extra fluids inside body to get a clearer image.

Medical imaging has gradually evolved in both diagnosis and therapy. In surgeries especially, the importance of virtual planning is increasing as it is still the only possible curative procedure. Visualization together with analysis of heart defects are also gaining in significance due to upgraded surgery techniques. The expansion and improvement in these advanced diagnostic imaging technologies is widely credited, leading to deliver accurate diagnoses of disease using non-invasive techniques as compared to the traditional ones.

These are some crucial factors to drive the growth of diagnostic imaging in North America especially US. However, the utilization and costs of advanced diagnostic imaging in the United States is very high and rapidly growing putting some challenges towards the diagnostic imaging market growth. The payments to physicians for diagnostic imaging have also monitored one of the highest growth among all physician services over the last decade making way for more potential opportunities related to the the market growth in future.

Computed tomography (CT) and magnetic resonance imaging (MRI) formed some of the largest segments for the diagnostic imaging market in North America. The CT scans are affordable and are generally used for the diagnosing patients at an initial stage. MRI scans are costlier and give a far more detailed diagnosis about the patient’s illness, helping the doctors to deliver correct medication at the right time. B

The North America is one of the major markets for Diagnostic Imaging North America with U.S. and Canada forming the two major regions profiled under the scope of this report. Changing healthcare infrastructure have propelled the usage of diagnostic imaging techniques. The medical imaging have come a long way and has seen numerous changes when it comes to timely diagnosis and getting real-time information about clients. These have together escalated the demand for diagnostic imaging in North America as more number of people get access to modern healthcare and expect faster diagnosis.

North America Diagnostic Imaging Market, Key Highlights:

• North America Diagnostic Imaging market size analysis and forecast
• Comprehensive study and analysis of market drivers, restraints, and opportunities influencing the growth of the North America Diagnostic Imaging market
• North America Diagnostic Imaging Market segmentation on the basis of applications, products, end-user, and geography
• North America Diagnostic Imaging Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of the study
• North America Diagnostic Imaging Market analysis and forecast for major countries has been provided.
• Profiling of key industry players, their strategic perspective, market positioning and analysis of core competencies
• Competitive landscape of the key players operating in the North America Diagnostic Imaging Market including competitive developments, investments, and strategic expansion

Key players of the North America Diagnostic Imaging market:

 Philips Healthcare
 GE Healthcare
 Toshiba Medical Systems Corporation
 Hitachi Ltd.
 Carestream Health, Inc.
 Esaote S.p.A
 Hologic, Inc.
 Siemens Healthcare GmBH
 Koninklijke Philips N.V
 Mindray Medical International
 Konica Minolta
 NeuSoft Medical
 Ziehm Imaging Inc
 Boston Scientific
 Varex Medical Systems
 Analogic Corp.
 Fujifilm Corporation
 Samsung
 Medison
 Shimadzu Corporation
 Abirex Inc.
 CurveBeam LLC

The scope of the North America Diagnostic Imaging Market: Inquire before buying

The research report segments North America Diagnostic Imaging market based on component, vertical, organization size, and geography.

North America Diagnostic Imaging Market, by Application:

• OB/GYN
• MSK
• Cardiology
• Oncology

North America Diagnostic Imaging Market, by Products:

• X-ray Imaging
• Digital
• Analog
• MRI
• Closed
• Open
• Ultrasound
• CT
• Nuclear Imaging
• SPECT
• Hybrid PET

North America Diagnostic Imaging Market, by End-User:

• Hospitals
• Imaging centers

North America Diagnostic Imaging Market, By Geography:

• North America
o US
o Canada

North America Diagnostic Imaging Market, Geographic Analysis

• Breakdown of US Diagnostic Imaging market
• Breakdown of Canada Diagnostic Imaging market

Available Customization

Maximize Market Research offers customizations of reports according to the specific requirement of our clients 





North America Diagnostic Imaging Market

1. EXECUTIVE SUMMARY
 2. RESEARCH METHODOLOGY
2.1. Market Definition
2.2. Market Scope
2.3. Data Sources
3. MARKET VARIABLES SCOPE
3.1. Market Segmentation Scope
3.2. Market Driver Analysis
3.3. Market Restraint Analysis
3.4. Porter’s Five Forces Analysis
3.5. PESTLE Analysis
4. NORTH AMERICA PRODUCT ESTIMATES TREND ANALYSIS (2019-2027)
4.1. Diagnostic Imaging Market: Product Analysis
4.2. X-ray Imaging
4.2.1. X-ray Imaging market, 2019-2027 (USD Billion)
4.3. Digital
4.3.1. Digital market, 2019-2027 (USD Billion)
4.4. Analog
4.4.1. Analog market, 2019-2027 (USD Billion)
4.5. MRI
4.5.1. MRI market, 2019-2027 (USD Billion)
4.6. Closed
4.6.1. Closed market, 2019-2027 (USD Billion)
4.7. Open
4.7.1. Open market, 2019-2027 (USD Billion)
4.8. Ultrasound
4.8.1. Ultrasound market, 2019-2027 (USD Billion)
4.9. CT
4.9.1. CT market, 2019-2027 (USD Billion)
4.10. Nuclear Imaging
4.10.1. Nuclear Imaging market, 2019-2027 (USD Billion)
4.11. SPECT
4.11.1. SPECT market, 2019-2027 (USD Billion)
4.12. Hybrid PET
4.12.1. Hybrid PET market, 2019-2027 (USD Billion)
5. NORTH AMERICA APPLICATION ESTIMATES TREND ANALYSIS (2019-2027)
5.1. Diagnostic Imaging Market: Application Analysis
5.2. OB/GYN
5.2.1. OB/GYN market, 2019-2027 (USD Billion)
5.3. MSK
5.3.1. MSK market, 2019-2027 (USD Billion)
5.4. Cardiology
5.4.1. Cardiology market, 2019-2027 (USD Billion)
5.5. Oncology
5.5.1. Oncology market, 2019-2027 (USD Billion)
6. NORTH AMERICA END-USER ESTIMATES TREND ANALYSIS (2019-2027)
6.1. Diagnostic Imaging Market: End-User Analysis
6.2. Hospitals
6.2.1. Hospitals market, 2019-2027 (USD Billion)
6.3. Imaging centers
6.3.1. Imaging centers market, 2019-2027 (USD Billion)
7. REGIONAL ESTIMATES TREND ANALYSIS (2019-2027)
7.1. Diagnostic Imaging market share by country, 2016 2025
7.2. US
7.2.1. US Diagnostic Imaging market, 2019-2027 (USD Billion)
7.3. Canada
7.3.1. Canada Diagnostic Imaging market, 2019-2027 (USD Billion)
8. MARKET SHARE ANALYSIS
8.1. Regional Diagnostic Imaging Market Share Analysis, by Key Players
8.1.1. US Diagnostic Imaging Market Share Analysis, by Key Players
8.1.2. Canada Diagnostic Imaging Market Share Analysis, by Key Players
8.2. Diagnostic Imaging Market: Key Innovators
8.3. Patent Analysis Year 2017
9. MARKET COMPETITION ANALYSIS
9.1. Strategy Framework
9.2. Company Profiles
9.2.1. Philips Healthcare
9.2.1.1. Company overview
9.2.1.2. Key financials
9.2.1.3. Product landscape
9.2.1.4. Strategic initiatives
9.2.1.5. SWOT analysis
9.2.2. GE Healthcare
9.2.2.1. Company overview
9.2.2.2. Key financials
9.2.2.3. Product landscape
9.2.2.4. Strategic initiatives
9.2.2.5. SWOT analysis
9.2.3. Toshiba Medical Systems Corporation
9.2.3.1. Company overview
9.2.3.2. Key financials
9.2.3.3. Product landscape
9.2.3.4. Strategic initiatives
9.2.3.5. SWOT analysis
9.2.4. Hitachi Ltd.
9.2.4.1. Company overview
9.2.4.2. Key financials
9.2.4.3. Product landscape
9.2.4.4. Strategic initiatives
9.2.4.5. SWOT analysis
9.2.5. Carestream Health, Inc.
9.2.5.1. Company overview
9.2.5.2. Key financials
9.2.5.3. Product landscape
9.2.5.4. Strategic initiatives
9.2.5.5. SWOT analysis
9.2.6. Esaote S.p.A
9.2.6.1. Company overview
9.2.6.2. Key financials
9.2.6.3. Product landscape
9.2.6.4. Strategic initiatives
9.2.6.5. SWOT analysis
9.2.7. Hologic, Inc.
9.2.7.1. Company overview
9.2.7.2. Key financials
9.2.7.3. Product landscape
9.2.7.4. Strategic initiatives
9.2.7.5. SWOT analysis
9.2.8. Siemens Healthcare GmBH
9.2.8.1. Company overview
9.2.8.2. Key financials
9.2.8.3. Product landscape
9.2.8.4. Strategic initiatives
9.2.8.5. SWOT analysis
9.2.9. Koninklijke Philips N.V
9.2.9.1. Company overview
9.2.9.2. Key financials
9.2.9.3. Product landscape
9.2.9.4. Strategic initiatives
9.2.9.5. SWOT analysis
9.2.10. Mindray Medical International
9.2.10.1. Company overview
9.2.10.2. Key financials
9.2.10.3. Product landscape
9.2.10.4. Strategic initiatives
9.2.10.5. SWOT analysis
9.2.11. Konica Minolta
9.2.11.1. Company overview
9.2.11.2. Key financials
9.2.11.3. Product landscape
9.2.11.4. Strategic initiatives
9.2.11.5. SWOT analysis
9.2.12. NeuSoft Medical
9.2.12.1. Company overview
9.2.12.2. Key financials
9.2.12.3. Product landscape
9.2.12.4. Strategic initiatives
9.2.12.5. SWOT analysis
9.2.13. Ziehm Imaging Inc
9.2.13.1. Company overview
9.2.13.2. Key financials
9.2.13.3. Product landscape
9.2.13.4. Strategic initiatives
9.2.13.5. SWOT analysis
9.2.14. Boston Scientific
9.2.14.1. Company overview
9.2.14.2. Key financials
9.2.14.3. Product landscape
9.2.14.4. Strategic initiatives
9.2.14.5. SWOT analysis
9.2.15. Varex Medical Systems
9.2.15.1. Company overview
9.2.15.2. Key financials
9.2.15.3. Product landscape
9.2.15.4. Strategic initiatives
9.2.15.5. SWOT analysis
9.2.16. Analogic Corp.
9.2.16.1. Company overview
9.2.16.2. Key financials
9.2.16.3. Product landscape
9.2.16.4. Strategic initiatives
9.2.16.5. SWOT analysis
9.2.17. Fujifilm Corporation
9.2.17.1. Company overview
9.2.17.2. Key financials
9.2.17.3. Product landscape
9.2.17.4. Strategic initiatives
9.2.17.5. SWOT analysis
9.2.18. Samsung
9.2.18.1. Company overview
9.2.18.2. Key financials
9.2.18.3. Product landscape
9.2.18.4. Strategic initiatives
9.2.18.5. SWOT analysis
9.2.19. Medison
9.2.19.1. Company overview
9.2.19.2. Key financials
9.2.19.3. Product landscape
9.2.19.4. Strategic initiatives
9.2.19.5. SWOT analysis
9.2.20. Shimadzu Corporation
9.2.20.1. Company overview
9.2.20.2. Key financials
9.2.20.3. Product landscape
9.2.20.4. Strategic initiatives
9.2.20.5. SWOT analysis
9.2.21. Abirex Inc.
9.2.21.1. Company overview
9.2.21.2. Key financials
9.2.21.3. Product landscape
9.2.21.4. Strategic initiatives
9.2.21.5. SWOT analysis
9.2.22. CurveBeam LLC
9.2.22.1. Company overview
9.2.22.2. Key financials
9.2.22.3. Product landscape
9.2.22.4. Strategic initiatives
9.2.22.5. SWOT analysis
  • INQUIRE BEFORE BUYING